HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jay Magaziner Selected Research

Warfarin (Coumadin)

1/2022Randomised comparative effectiveness trial of Pulmonary Embolism Prevention after hiP and kneE Replacement (PEPPER): the PEPPER trial protocol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jay Magaziner Research Topics

Disease

13Dementia (Dementias)
03/2016 - 08/2002
9Pain (Aches)
01/2022 - 03/2002
6Osteoporosis
01/2017 - 06/2004
5Hip Fractures (Intertrochanteric Fractures)
01/2020 - 09/2003
5Pressure Ulcer (Bedsore)
02/2012 - 11/2003
4Infections
03/2015 - 12/2002
3Delirium
11/2021 - 01/2003
3Inflammation (Inflammations)
01/2020 - 10/2012
3Pneumonia (Pneumonitis)
08/2015 - 12/2002
3Anemia
08/2013 - 07/2004
3Wounds and Injuries (Trauma)
12/2011 - 09/2003
2Vitamin D Deficiency
01/2019 - 12/2007
2Cognitive Dysfunction
03/2016 - 09/2003
2Stroke (Strokes)
08/2015 - 10/2004
2Myocardial Infarction
08/2015 - 10/2004
2Cardiovascular Diseases (Cardiovascular Disease)
03/2015 - 08/2013
2Suppuration
02/2012 - 08/2004
1Venous Thromboembolism
01/2022
1Pulmonary Embolism
01/2022
1Hemorrhage
01/2022
1Emergence Delirium
11/2021
1COVID-19
01/2021
1Sarcopenia
01/2020
1Mobility Limitation (Difficulty Walking)
01/2020
1Bone Resorption
01/2018
1Femoral Fractures (Femoral Fracture)
08/2015
1Neoplasms (Cancer)
03/2015
1Diabetes Mellitus
09/2009
1Fever (Fevers)
11/2005
1Heart Failure
10/2004
1Postoperative Pain
06/2003
1Urinary Incontinence
08/2002
1Hip Osteoarthritis (Coxarthrosis)
03/2002

Drug/Important Bio-Agent (IBA)

3CalciumIBA
01/2017 - 10/2004
3Hemoglobins (Hemoglobin)IBA
08/2013 - 07/2004
3Interleukin-6 (Interleukin 6)IBA
10/2012 - 10/2006
3Zoledronic Acid (Zometa)FDA Link
12/2011 - 06/2004
3Anti-Bacterial Agents (Antibiotics)IBA
07/2008 - 12/2002
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022 - 10/2004
2Analgesics (Analgesic Drugs)IBA
01/2022 - 01/2003
2Brain-Derived Neurotrophic Factor (BDNF)IBA
08/2019 - 01/2016
2hydroxide ionIBA
01/2019 - 12/2007
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 10/2012
2Opioid Analgesics (Opioids)IBA
06/2003 - 01/2003
1RivaroxabanIBA
01/2022
1Warfarin (Coumadin)FDA LinkGeneric
01/2022
1Testosterone (Sustanon)FDA Link
01/2021
1ORALIT (ORS)IBA
01/2020
1Lactic Acid (Lactate)FDA LinkGeneric
01/2020
1KetonesIBA
01/2020
1Fatty Acids (Saturated Fatty Acids)IBA
01/2020
1Amino AcidsFDA Link
01/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1AntioxidantsIBA
10/2012
1Vitamin EFDA LinkGeneric
10/2012
1Carotenoids (Carotene)IBA
10/2012
1Diphosphonates (Bisphosphonates)IBA
12/2011
1Indicators and Reagents (Reagents)IBA
09/2009
1CytokinesIBA
10/2006
1Pharmaceutical PreparationsIBA
12/2005
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2004
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
10/2004
1AnticoagulantsIBA
10/2004
1Meperidine (Pethidine)FDA LinkGeneric
01/2003
1Morphine (MS Contin)FDA LinkGeneric
01/2003

Therapy/Procedure

16Home Nursing (Nursing, Home)
08/2015 - 12/2002
6Therapeutics
01/2021 - 12/2002
6Length of Stay
11/2019 - 03/2002
3Long-Term Care
03/2016 - 11/2003
2General Anesthesia
01/2022 - 11/2021
2Spinal Anesthesia
01/2022 - 11/2021
2Anesthesia
11/2021 - 09/2003
2Activities of Daily Living (ADL)
08/2019 - 08/2002
2Blood Transfusion (Blood Transfusions)
03/2015 - 08/2013
2Continuity of Patient Care
04/2010 - 05/2009
1Chemoprevention
01/2022
1Walkers
01/2020
1Subacute Care
03/2016
1Institutionalization (Institutionalized Persons)
08/2015
1Inappropriate Prescribing
12/2005
1Physical Therapy Modalities (Physical Therapy Technique)
06/2003
1Analgesia
01/2003
1Hip Replacement Arthroplasty (Total Hip Replacement)
03/2002